Sula Test
Dr. Of Cosmetology, Harvard Medical
Location: United States
Recently Online
Consulting Services
Areas Of Interest
Professional Narrative
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Viverra mauris in aliquam sem fringilla ut morbi tincidunt. A arcu cursus vitae congue mauris rhoncus aenean vel elit. Nec tincidunt praesent semper feugiat nibh sed pulvinar. In iaculis nunc sed augue lacus. Dis parturient montes nascetur ridiculus mus mauris vitae. Libero volutpat sed cras ornare arcu dui. Ullamcorper velit sed ullamcorper morbi tincidunt ornare. Quis vel eros donec ac odio tempor. Lorem donec massa sapien faucibus et molestie. Nunc lobortis mattis aliquam faucibus purus in massa tempor nec. Nec ullamcorper sit amet risus. Sed cras ornare arcu dui vivamus arcu felis. Augue eget arcu dictum varius duis at consectetur lorem donec.
Consequat interdum varius sit amet mattis vulputate enim nulla. Rhoncus dolor purus non enim. Aliquam purus sit amet luctus. In hac habitasse platea dictumst vestibulum rhoncus est. Duis at consectetur lorem donec massa sapien faucibus. Nunc congue nisi vitae suscipit tellus mauris a. Arcu odio ut sem nulla pharetra diam sit. Pellentesque massa placerat duis ultricies lacus sed turpis. Lectus vestibulum mattis ullamcorper velit. Ut enim blandit volutpat maecenas volutpat. Egestas maecenas pharetra convallis posuere morbi leo urna molestie. Vitae aliquet nec ullamcorper sit amet risus. Consequat ac felis donec et odio pellentesque diam volutpat.
Consequat nisl vel pretium lectus quam id leo. Sem integer vitae justo eget magna fermentum iaculis eu non. Feugiat pretium nibh ipsum consequat. Sed euismod nisi porta lorem mollis. Velit dignissim sodales ut eu. Ac felis donec et odio pellentesque diam. Eget dolor morbi non arcu risus. Lacinia at quis risus sed vulputate odio ut. Turpis cursus in hac habitasse platea dictumst. Vel pharetra vel turpis nunc. Scelerisque eu ultrices vitae auctor. Urna porttitor rhoncus dolor purus non enim praesent elementum. Lobortis mattis aliquam faucibus purus. Quam adipiscing vitae proin sagittis. Eget aliquet nibh praesent tristique magna. Amet facilisis magna etiam tempor orci eu lobortis elementum nibh. Non arcu risus quis varius. Scelerisque viverra mauris in aliquam sem fringilla ut morbi. Natoque penatibus et magnis dis parturient.
Dolor sed viverra ipsum nunc aliquet bibendum enim facilisis. Malesuada fames ac turpis egestas sed. Libero id faucibus nisl tincidunt eget nullam non nisi est. Commodo viverra maecenas accumsan lacus vel facilisis volutpat est velit. Amet cursus sit amet dictum sit amet justo. At imperdiet dui accumsan sit amet nulla facilisi morbi. Volutpat lacus laoreet non curabitur gravida arcu. Sagittis orci a scelerisque purus semper eget duis. Ut lectus arcu bibendum at varius vel. Vehicula ipsum a arcu cursus vitae. Mattis enim ut tellus elementum sagittis vitae et leo.
Mauris commodo quis imperdiet massa. Placerat vestibulum lectus mauris ultrices eros in cursus turpis massa. Condimentum id venenatis a condimentum vitae sapien. Non pulvinar neque laoreet suspendisse interdum consectetur. Nulla aliquet enim tortor at auctor. Erat imperdiet sed euismod nisi. Ut aliquam purus sit amet luctus. In cursus turpis massa tincidunt dui ut. Fermentum odio eu feugiat pretium nibh ipsum. Tincidunt id aliquet risus feugiat in ante metus. Ornare quam viverra orci sagittis eu volutpat odio facilisis mauris. Nulla aliquet porttitor lacus luctus accumsan tortor posuere. Nulla facilisi etiam dignissim diam. Mattis vulputate enim nulla aliquet porttitor. Tristique risus nec feugiat in fermentum. Malesuada fames ac turpis egestas. Scelerisque fermentum dui faucibus in ornare quam viverra. Augue interdum velit euismod in pellentesque massa placerat duis. Sem integer vitae justo eget. A condimentum vitae sapien pellentesque habitant morbi.
Employment
Education
Referees
Publications
1: Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer
immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi:
10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.
2: Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine
delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi:
10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID:
27075952; PMCID: PMC5439223.
3: Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R.
Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021
Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID:
33277608; PMCID: PMC7717100.
4: Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat
Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug
10. PMID: 34394960; PMCID: PMC8353930.
5: Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016
Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID:
26711689; PMCID: PMC4733916.
6: Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O,
Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ,
Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR-
Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct
9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID:
25263330; PMCID: PMC4265475.
7: Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery.
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7.
Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.
8: Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for
therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi:
10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.
9: Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim
JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science
perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi:
10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.
10: Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell
Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi:
10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.
11: Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A,
Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery
for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi:
10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID:
PMC5523404.
12: Abramson A, Caffarel-Salvador E, Khang M, Dellal D, Silverstein D, Gao Y,
Frederiksen MR, Vegge A, Hubálek F, Water JJ, Friderichsen AV, Fels J, Kirk RK,
Cleveland C, Collins J, Tamang S, Hayward A, Landh T, Buckley ST, Roxhed N,
Rahbek U, Langer R, Traverso G. An ingestible self-orienting system for oral
delivery of macromolecules. Science. 2019 Feb 8;363(6427):611-615. doi:
10.1126/science.aau2277. PMID: 30733413; PMCID: PMC6430586.
Grants,Awards and Certifications
Grants :
1: Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer
immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi:
10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.
2: Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine
delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi:
10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID:
27075952; PMCID: PMC5439223.
3: Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R.
Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021
Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID:
33277608; PMCID: PMC7717100.
4: Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat
Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug
10. PMID: 34394960; PMCID: PMC8353930.
5: Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016
Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID:
26711689; PMCID: PMC4733916.
6: Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O,
Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ,
Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR-
Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct
9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID:
25263330; PMCID: PMC4265475.
7: Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery.
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7.
Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.
8: Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for
therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi:
10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.
9: Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim
JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science
perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi:
10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.
10: Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell
Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi:
10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.
11: Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A,
Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery
for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi:
10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID:
PMC5523404.
12: Abramson A, Caffarel-Salvador E, Khang M, Dellal D, Silverstein D, Gao Y,
Frederiksen MR, Vegge A, Hubálek F, Water JJ, Friderichsen AV, Fels J, Kirk RK,
Cleveland C, Collins J, Tamang S, Hayward A, Landh T, Buckley ST, Roxhed N,
Rahbek U, Langer R, Traverso G. An ingestible self-orienting system for oral
delivery of macromolecules. Science. 2019 Feb 8;363(6427):611-615. doi:
10.1126/science.aau2277. PMID: 30733413; PMCID: PMC6430586.
Awards & Prizes :
1: Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer
immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi:
10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.
2: Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine
delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi:
10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID:
27075952; PMCID: PMC5439223.
3: Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R.
Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021
Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID:
33277608; PMCID: PMC7717100.
4: Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat
Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug
10. PMID: 34394960; PMCID: PMC8353930.
5: Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016
Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID:
26711689; PMCID: PMC4733916.
6: Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O,
Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ,
Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR-
Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct
9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID:
25263330; PMCID: PMC4265475.
7: Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery.
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7.
Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.
8: Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for
therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi:
10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.
9: Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim
JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science
perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi:
10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.
10: Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell
Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi:
10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.
11: Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A,
Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery
for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi:
10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID:
PMC5523404.
12: Abramson A, Caffarel-Salvador E, Khang M, Dellal D, Silverstein D, Gao Y,
Frederiksen MR, Vegge A, Hubálek F, Water JJ, Friderichsen AV, Fels J, Kirk RK,
Cleveland C, Collins J, Tamang S, Hayward A, Landh T, Buckley ST, Roxhed N,
Rahbek U, Langer R, Traverso G. An ingestible self-orienting system for oral
delivery of macromolecules. Science. 2019 Feb 8;363(6427):611-615. doi:
10.1126/science.aau2277. PMID: 30733413; PMCID: PMC6430586.
